BeOne Medicines' investigational Bruton's tyrosine kinase (BTK) degrader, BGB-16673, has received priority medicines (PRIME) designation.

Key Points Revenue (GAAP) reached $124.1 million, surpassing the $115.5 million GAAP estimate and rising 29.7% year-over-year. Non-GAAP earnings per share improved to ($0.24), beating expectations and ...

Sun Pharmaceutical Industries reported a decline of 20 per cent in net profit at Rs. 2,278.63 crore during the first quarter of the current fiscal year, as compared to Rs. 2,835.62 crore during the ...

President Donald Trump on Wednesday announced the imposition of a 25 per cent tariff on all goods coming from India starting ...

Officials argue the military can help keep drug prices affordable and accessible. Experts, who say public health and safety ...

Industry insiders say any rise in duties on Indian generics will squeeze profits for Indian companies, but will also make the ...

President Trump escalated efforts to reduce drug prices in the US on Thursday, releasing letters sent to 17 pharmaceutical ...

Patient advocacy organizations across the United States are intensifying their efforts to expand access to experimental therapies, arguing that current regulatory frameworks create unnecessary ...

July 31, 2025 \| Last updated: July 31, 2025. More for You ...

Mariners' Team Plane Made Special Move for Eugenio Suarez After Blockbuster Trade I ask this question first in every job interview. It's transformed how I hire.

It is hard to imagine someone more equipped and more dedicated to vetting treatments than Vinay Prasad,” writes his former ...

Company expects to complete Phase 3 Aspire study in the second half of 2026. Aurora study of GTX-102 in additional ages and ...